Razan Mansour

Glad to share our @Yale tour-de-force review of #MDSsm published in @Nature Reviews of Clinical Oncology (Free online read at rdcu.be/fdl9e) which has to be the most comprehensive review we have ever written on the subject covering all relevant areas from epidemiology, pathogenesis, diagnosis, risk stratification, to current and evolving therapies for lower and higher risk disease @YaleCancer @YaleHematology @YaleMed

Congratulations to an amazing new class of fellows @YaleCancer @YaleHematology @YaleHemOnc @Yale Looking forward to seeing all the great things you will do..

Welcome to an outstanding group of heme/onc fellows joining @YaleCancer @YaleMed @YaleHematology @YaleHemOnc & a special welcome to dr Razan Mansour who is the first 🇯🇴 female fellow to join the combined Heme/Onc fellowship at @Yale following footsteps of @tariqkewan the first 🇯🇴 fellow, congratulations to all.

#ASH24 #mmsm @ASH_hematology Nice algorithm for therapeutic anticoagulation for cancer associated VTE

#ASH24 @ASH_hematology #mmsm Summary of recent immunotherapy in R/R MM with EMA and FDA approvals

@JOEBENNETTMD @Abdallah81MD @KortJeries @USMIRCNEWS @ASH_hematology @OncoAlert @KUcancercenter Thank you!! So excited!

@Abdallah81MD @ramansour95 @KortJeries @USMIRCNEWS @ASH_hematology @OncoAlert @KUcancercenter Congrats @ramansour95 you are going to love fellowship :)

We're so excited for our future Hematologist, @ramansour95, who is about to start her fellowship at Yale! @KortJeries #mmsm #MedTwitter #USMIRC @USMIRCNEWS #ASH24 @ASH_hematology @OncoAlert @KUcancercenter

@Abdallah81MD @KortJeries @USMIRCNEWS @ASH_hematology @OncoAlert @KUcancercenter Thank you so much, Dr. Abdallah! Couldn’t have done it without your mentorship!!!

🎉 Huge shoutout to our amazing mentees for your dedication during residency! Your hard work on research projects has led to matching for Heme-Onc Fellowship! We’re so proud of you, @ramansour95 @venkat28priya @DrAliyaRashid! Let’s celebrate! 🌟 #USMIRC @KUMedCenter @USMIRCNEWS @OncoAlert #MedTwitter

With my apologies to toddler parents everywhere… “Don’t lose it, reuse it!” Excellent @BloodAdvances work by Goel @MayoMyeloma @VincentRK @myelomaMD et al. Re-using old myeloma #MMsm drugs can work, esp if years out. Very relevant to post-CAR-T! ashpublications.org/bloodadvances/…

🧵 ASH abstracts via #USMIRC group (Myeloma subdivision): 3317 Optimal Treatment for Newly Diagnosed Primary Plasma Cell Leukemia: Multicenter Analysis By @venkat28priya Barry Paul MD #mmsm #medtwitter #ASH2024 @KUcancercenter @LevineCancer ash.confex.com/ash/2024/webpr…

🧵 ASH abstracts via #USMIRC group (Myeloma subdivision) 1965 Comparative Efficacy of DPd Compared to DKd in Patients with RRMM Aged 70 and Above: A Multicenter Study. Present by @ramansour95 @KUcancercenter @hhashmi87 #MedTwitter #mmsm #ASH2024 ash.confex.com/ash/2024/webpr…

DPd Vs DKd in RRMM in a retrospective study: ash.confex.com/ash/2023/webpr… #mmsm #myeloma #MedTwitter #MedEd @OncoAlert @thisisJamesD @Rawana_97 @DimaDanai @NausheenAhmedMD #USMIRC #ASH23

Daratumumab-Based Regimens in Anti-CD38 Treatment-Naïve Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics OS in 2+ HRCyto RRMM 22.5 months! @j_snyder0132 @hhashmi87 @AimazAfrough @AtrashShebli @mumairmushtaq @NausheenAhmedMD #USMIRC #mmsm #myeloma #MedTwitter #MedEd #ASH23 @OncoAlert ash.confex.com/ash/2023/webpr…

Congratulations 🎉 to our #USMIRC group for getting 15 abstracts accepted @ASH_hematology and 7 online! Outstanding effort! Congratulations to the Mentors who assist all mentees during this journey and provide guidance 🙏 #MedTwitter #medEd #mmsm #myeloma @OncoAlert

Congratulations 🎉🎊🎈 for our mentees and mentors #USMIRC group for getting their abstracts accepted @ASH_hematology 👏🏻👏🏻👏🏻 @KUcancercenter #mmsm #myeloma #MedTwitter #MedEd

Getting ready for KUMC Internal Medicine Research Day. Posters Printing ✅️ @Reem_A_Mustafa @ramansour95 @KUMedCenter @KUJGKI @KUNeph @KUIMchiefs

The eCOVID-19 team would like to recognize and thank all volunteers who have contributed to our plain language recommendation work for the RecMap!